Small Lymphocytic Lymphoma
📧 Sign up to get email alerts when something new happens for Small Lymphocytic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors [Phase 3]
A Phase 3 study evaluating BGB-16673 versus investigator's choice in relapsed/refractory chronic lymphocytic leukemia or small lymphocytic l…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL [Phase 1, Phase 2]
Phase I/II clinical trial update describing the study of Rapcabtagene Autoleucel in chronic lymphocytic leukemia, small lymphocytic lymphoma…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies [Phase 1]
NX-5948 is being studied in a Phase 1 trial for adults with relapsed/refractory B-cell malignancies; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial update for customizing ibrutinib treatment regimens in previously untreated chronic lymphocytic leukemia and small lymphocytic…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T [Phase 1]
This clinical trial update reports long-term follow-up results from a Phase 1 study of CLBR001 CAR-T cells in relapsed/refractory B-cell lym…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial update evaluating ibrutinib as an immune-modulating agent for asymptomatic, high-risk chronic lymphocytic leukemia or small ly…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating pirtobrutinib for relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma is …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS [Phase 1, Phase 2]
Clinical trial update on the Phase 1/2 study of the duvelisib and venetoclax combination in relapsed or refractory Chronic Lymphocytic Leuke…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Zanubrutinib and Rituximab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 trial evaluating the combination of zanubrutinib and rituximab for previously untreated chronic lymphocytic leukemia or small lymp…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML [Phase 1]
Phase 1 trial update for voruciclib alone or with venetoclax in various B-cell malignancies and acute myeloid leukemia; the study has been t…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of lenalidomide with DA-EPOCH-R in MYC-associated B-cell lymphomas has completed, and results hav…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating ixazomib citrate with rituximab in indolent B-cell non-Hodgkin lymphoma has posted results.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2) [Phase 1, Phase 2]
Clinical Trial Update on the ALPHA2 Phase 1/2 study evaluating ALLO-501A anti-CD19 allogeneic CAR T cells in adults with relapsed/refractory…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab [Phase 1, Phase 2]
BeiGene announced completion and posted results for a Phase 1/2 study of BGB-10188 as monotherapy and in combination with zanubrutinib and t…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study
Post-marketing surveillance study in Japan evaluating Calquence (acalabrutinib) as first-line therapy for previously untreated chronic lymph…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial update evaluating venetoclax in combination with ibrutinib for chronic lymphocytic leukemia and small lymphocytic lym…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome [Phase 2]
Phase 2 clinical trial evaluating a triple-drug regimen (atezolizumab, obinutuzumab, and venetoclax) for chronic lymphocytic leukemia, small…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia [Phase 3]
A Phase 3 trial is evaluating whether adding venetoclax to the standard combination of ibrutinib and obinutuzumab improves outcomes in untre…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial of the oral BTK inhibitor LOXO-305 (pirtobrutinib) in patients with previously treated chronic lymphocy…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies [Phase 1]
A Phase 1 clinical trial evaluates PRT2527 as a standalone therapy and in combination with zanubrutinib or venetoclax for relapsed/refractor…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab [Phase 2]
Phase 2 study evaluating disease risk mutation-guided finite acalabrutinib plus venetoclax for relapsed chronic lymphocytic leukemia and sma…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL [Phase 3]
A Phase 3 global trial (ROCKET-CLL) comparing rocbrutinib to pirtobrutinib in patients previously treated with covalent BTK inhibitors and w…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 1]
Phase 1 trial update of ABBV-453 in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma, focusing on adverse eve…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating an anti-pneumococcal vaccine strategy in patients with Chronic Lymphocytic Leukemia and Small lymphocyti…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL [Phase 1]
Clinical trial update for a Phase 1 study evaluating autologous peripheral blood lymphocytes in chronic lymphocytic leukemia and small lymph…